期刊文献+

40例直肠胃肠间质瘤的预后分析 被引量:3

Prognostic analysis of 40 cases with rectal gastrointestinal stromal tumor
原文传递
导出
摘要 目的探讨直肠胃肠间质瘤(GIST)的预后特点。方法对新疆医科大学附属中医医院和天津市人民医院1979年6月至2010年6月间收治的40例直肠GIST患者的临床和随访资料进行回顾性分析。结果40例直肠GIST中男性23例,女性17例,年龄28~81(中位数54.5)岁。术后随访1~300(中位52.5)个月,复发和转移18例,其中单纯局部复发7例,单纯远处转移6例,局部复发并远处转移5例。术后1、3及5年生存率分别为82.5%、60.0%及42.5%。单因素预后分析显示。患者术后生存率与肿瘤大小(P〈0.01)、肿瘤Fletcher分级(P〈0.01)、核分裂像(P〈0.01)及术后远处转移(P〈0.05)有关;多因素预后分析显示,肿瘤大小(P〈0.05)、核分裂像(P〈0.01)和术后远处转移fP〈0.01)是直肠GIST的独立预后因素。结论直肠GIST治疗仍以手术切除为主,肿瘤原发灶大小、核分裂像和术后远处转移是影响预后的独立因素。 [Abstract] Objective To analyze the prognosis of rectal gastrointestinal stromal tumors (GIST). Methods Records of 40 patients diagnosed as rectal GIST at the Affiliated Chinese Traditional Medical Hospital of Xinjiang Medical University and the People's Hospital of Tianjin City between June 1979 and June 2010 were reviewed. Clinical features, treatment modalities and outcomes were analyzed. Results There were 23 males and 17 females with a median age of 54.5 years old (range, 28-81 years old). During the follow-up (median 52.5 months, range 1-300 months), 18 patients developed recurrence including 7 local recurrence, 6 metastasis and 5 local recurrence complicated with metastasis. The overall survival rates at 1, 3 and 5 years were 82.5%, 60.0%, and 42.5% respectively. On univariate analysis, tumor size (P〈0.01), Fletcher classification (P〈0.01), mitotic index (P〈0.01), and post- operative distant metastasis were associated with survival. Multivariate analysis showed that tumor size (P〈0.05), mitotic rate (P〈0.01), and postoperative distant metastasis (P〈0.01) were independent prognostic factors associated with survival. Conclusions Surgery is the main treatment for rectal GIST. Tumor size, mitotic rate and metastasis are independent prognostic factors in patients with rectal GIST.
出处 《中华胃肠外科杂志》 CAS 2012年第3期263-265,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肠间质瘤 直肠 外科手术 肿瘤复发 肿瘤转移 预后 Gastrointestinal stromal tumors,rectum Surgical procedures Tumor recurrence Tumor metastasis Prognosis
  • 相关文献

参考文献8

  • 1张威,叶再元,邵钦树,赵仲生,王跃东,许晓东.胃肠道间质瘤的临床研究[J].中华胃肠外科杂志,2009,12(4):378-381. 被引量:7
  • 2DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumours : recurrence patterns and prognostic factors for survival. Ann Surg, 2000,231 (1):51-58.
  • 3Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol, 2002,26(6):705-714.
  • 4伍小军,万德森,卢震海,方淯靖,彭志恒,陈功,李力人,林俊忠,丁培荣,孔令亨,潘志忠.32例直肠间质瘤临床分析[J].广东医学,2010,31(10):1324-1327. 被引量:6
  • 5Eisenberg BL, Smith KD. Adjuvant and neoadjuvant therapy for primary GIST. Cancer Chemother Pharmacol, 2011,67 (Suppl 1 ) : S3-S8.
  • 6Machairas A, Karamitopoulou E, Tsapralis D, et al. Gastrointestinal stromal tumors (GISTs): An updated experience. Dig Dis Sci, 2010,55(12) : 3315-3327.
  • 7Vassos N, Agaimy A, Schlabrakowski A, et al. An unusual and potentially misleading phenotypic changein a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy. Virchows Arch, 2011,458 (3) : 363-369.
  • 8李建胜,俞美萍,莫善兢.结直肠间质瘤的临床病理特点和外科处理[J].中华普通外科杂志,2010,25(8):645-648. 被引量:2

二级参考文献27

  • 1KITAMURA Y.Gastrointestinal stromal tumors:past,present,and future[J].Gastroenterol,2008,43(7):499-508.
  • 2DONG C,JUN HUI C,XIAO JUN Y,et al.Gastrointestinal stromal tumo rs of the rectum:Clinical,patho logic,immunohistochemical characteristics and prognostic analysis[J].Scand J Gastroenterol,2007,42(10):1221-1229.
  • 3KIRSCH R,GAO Z H,RIDDELL R.Gastrointestinal stromal tumors diagnostic challenges and practical approach to differential diagno sis[J].Adv Anat Pathol,2007,14(4):261-285.
  • 4VANDER NOOT M R 3rd,ELOUBEIDI M A,CHEN V K,et al.Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy[J].Cancer,2004,102(3):157-163.
  • 5RAUT C P,DEMATTEO R P.Prognostic factors for primary GIST:prime time for personalized therapy?[J].Ann Surg Oncol,2008,15(1):4-6.
  • 6DEMETRI G D,BENJAMIN R S,BLANKE C D,et al.NCCN Task Force report:management of patients with gastrointestinal stromal tumor(GIST)--update of the NCCN clinical practice guidelines[J].J Natl Compr Canc Netw,2007,5(Suppl 2):S1-29.
  • 7KEUN PARK C,LEE E J,KIM M,et al.Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy[J].Ann Surg,2008,247(6):1011-1018.
  • 8DEMATTEO R P,GOLD J S,SARAN L,et al.Tumor mitotic rate,size,and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)[J].Cancer,2008,112(3):608-615.
  • 9BRACONI C,BRACCI R,BEARZI I,et al.Insulin-like growth factor(IGF)1 and 2 help topredict disease outcome in GIST patients[J].Ann Oncol,2008,19(7):1293-1298.
  • 10HASSAN I,YOU Y N,SHYYAN R,et al.Surgically managed gastrointestinal stromal tumors:a comparative and prognostic analysis[J].Ann Surg Oncol,2008,15(1):52-59.

共引文献11

同被引文献28

  • 1苏向前,崔明,冷家骅,武爱文,王怡.直肠间质瘤的诊断和治疗[J].中国实用外科杂志,2006,26(8):605-606. 被引量:3
  • 2冯奉仪.实体瘤新的疗效评价标准(解读1.1版RECIST标准)[C].第三届中国肿瘤内科大会教育集暨论文集,2009.
  • 3王天宝,卫洪波,邱万寿,魏波,董文广.68例胃肠间质瘤临床病理及预后分析[J].中国现代普通外科进展,2007,10(5):409-411. 被引量:4
  • 4Serrano C.Recent advances in the treatment of gastroin- testinal stromal tumors[J].Ther Adv Med Oncol,2009,6(3) : 115-127.
  • 5Yeh CH, Pan KT, Chu SY,et al.Safety and efficacy of image- guided percutaneous biopsies in the diagnosis of gastrointestinal stromal tumors[J]. Clin Imaging, 2012,36( 1 ) : 19-23.
  • 6Shankar S, Dundamadappa SK, Karam AR, et al. Imaging of gas- trointestinal stromal tumors before and after imatinib mesylate therapy[ J]. Acta Radiol, 2009,50(8) :837-44.
  • 7Cohen MH, Johnson JR, Justice R, et al. Approval summary: Imatinib mesylate for one or three years in the adjuvant treatment of gastrointestinal stromal tumors [ J ]. Oncologist, 2012,17 ( 7 ) : 992-997.
  • 8Amitay-Laish I, Stemmer SM, Lacouture ME.Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib. [ J]. Dermatol Ther, 2011,24(4) :386-395.
  • 9程云生,刘弋,曹先东,汪圣毅.胃肠道间质瘤109例临床诊治及病理学分析[J].实用医学杂志,2008,24(19):3346-3348. 被引量:5
  • 10杨柳青,秦叔逵.GIST分子靶向药物疗效评价的新标准[J].临床肿瘤学杂志,2008,13(10):942-947. 被引量:11

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部